MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD is expecting to see an additional $200 million layered onto its costs this year as a result of President Trump's tariffs – even before a possible pharma-specific levy is announced. The US pharma ...

The West woke up Wednesday to news of a Lexus LS comeback that was announced at the 2025 Japan Mobility Show. However, it’s no longer the flagship sedan we all know and love. Instead, Lexus assigned ...

Merck & Co (MSD) has broken ground on its new pharmaceutical manufacturing Centre of Excellence in Virginia, US, amid looming tariff threats from the Trump administration. The $3bn site, which is ...

Adam Piekarski decided to go it alone after more than a decade at BDT & MSD Partners. He’s backing up that bet with a historic unveiling. Derby Lane Partners has amassed $1.8 billion in commitments ...

It sure looks like we've come to the end of the line with the Lexus LS. After launching it 36 years ago for the 1990 model year, the automaker looks to be offering the LS a fond farewell with the 2026 ...

It’s been more than three decades since Toyota introduced its luxury division with the original Lexus LS 400. Launched in 1989 as a 1990MY, the full-size sedan proved you didn’t need a German passport ...

MSD (Merck & Co., Inc.) will vacate its laboratories at the Francis Crick Institute in London by end‑2025 as it winds down discovery research in the UK. The move follows the decision to scrap a ...

Back in 1955, General Motors gave birth to one of America's most iconic engines, the Chevy small-block V8. Among these, the LS series, also known as the third and fourth generations of small block V8, ...

Summit founder and president Quint Rubald, CEO Jeff Evrard and the broader management team will remain shareholders and continue to lead the company Founded in 1999, Summit has locations across 37 ...

MSD is slashing $3bn (€2.59bn) from its annual spending as it braces for off-brand competition to its Irish-manufactured cancer drug Keytruda, the best-selling medicine in the world. The drugmaker ...

BDT & MSD Partners alum Adam Piekarski is starting anew and has formed Derby Lane Partners, a new real estate credit investment firm, according to a person with knowledge of the matter. New York-based ...